Melissa Ronan

25PUBLICATIONS
370CO-AUTHORS
Gene and molecular therapyPredictive and prognostic markersBiomolecular modelling and designMolecular targetsCheminformatics and quantitative structure-activity relationships
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (25)

|Sep 29, 2026
Targeting O6-methylguanine-DNA Methyltransferase Deficiency in Preclinical Models of Extracranial Human Cancers with a Tumor-Selective DNA-Modifying Agent.

|Sep 27, 2026
Histone H4 lysine 20 tri-methylation safeguards breast cancer lineage fidelity and unfolded protein response.

|Sep 23, 2026
A design approach for bitopic kinase inhibitors.

|May 22, 2026
Genetic Drivers of Sensitivity or Resistance to RAS(ON) Multiselective Inhibitors in NRAS-Mutated Melanoma.

|Oct 27, 2025
PI3Kα Inhibitor and Degrader Inavolisib Can Co-opt FGFR2 to Enhance Responses in Patients with PIK3CA-Mutated Solid Tumors and in Preclinical Models.

Dejan Juric, Kyung Song, Radia M Johnson

|Oct 03, 2025
Targeting histone H2B acetylated enhanceosomes via p300/CBP degradation in prostate cancer.

Jie Luo, Zhixiang Chen, Yuanyuan Qiao

Pageof 5

Frequent Collaborators

25 joint publications

Jennifer Roth

24 joint publications

Matthew Rees

6 joint publications

Andrew S Boghossian

4 joint publications

Jacqueline A M Smith